Catalyst Wire Dossier Catalyst Wire Dossier

TRIKAFTA

ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR · Vertex Pharmaceuticals Incorporated
Drug timelines are a Plus or Pro feature.

34 regulatory and trial events tracked for TRIKAFTA, covering 2019-10-21 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-Ivacaftor [NA]

See pricing